{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:47:13Z","timestamp":1793227633929,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003460.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T00:00:00Z","timestamp":1312934400000}}],"reference-count":303,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003460.pub3","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T00:51:16Z","timestamp":1312419076000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome"],"prefix":"10.1002","volume":"2013","author":[{"given":"Lisa","family":"Ruepert","sequence":"first","affiliation":[{"name":"University Medical Center Utrecht; P.O. Box 85060 3508 AB Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Otto","family":"Quartero","sequence":"additional","affiliation":[{"name":"Huisartspraktijk Diepenveen; Dorpsstraat 16 Diepenveen Netherlands 7431 CK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek J","family":"de Wit","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Julius Center for Health Sciences and Primary Care; PO Box 85500 Utrecht Netherlands 3508 GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J","family":"van der Heijden","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Department of Otorhinolaryngology & Julius Center for Health Sciences and Primary Care; PO Box 85500 Internal postal address STR 6.131 Utrecht Netherlands 3508 GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Rubin","sequence":"additional","affiliation":[{"name":"Durham University; School of Medicine and Health, Wolfson Research Institute Queen's Campus, University Boulevard Stockton on Tees UK TS17 6BH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean WM","family":"Muris","sequence":"additional","affiliation":[{"name":"Maastricht University; Department of General Practice; Maastricht University Medical Centre, Care and Public Health Research Institute (CAPHRI) PO Box 616 Maastricht Netherlands 6200 MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,10]]},"reference":[{"key":"10.1002\/14651858.CD003460.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.nut.2004.05.016","article-title":"Dietary intake of a group of patients with irritable bowel syndrome; relation between dietary fiber and symptoms","volume":"20","author":"Aller","year":"2004","journal-title":"Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0002|cit2","first-page":"253","article-title":"Double blind trial of ispaghula\/poloxamer in the irritable bowel syndrome","volume":"76","author":"Arthurs","year":"1983","journal-title":"Ir Med J"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0003|cit3","first-page":"137","article-title":"Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial","volume":"25","author":"Awad","year":"1995","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jpeds.2008.08.011","article-title":"Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents","volume":"153","author":"Bahar","year":"2008 Dec","journal-title":"J Pediatr"},{"issue":"8 Suppl 1","key":"10.1002\/14651858.CD003460.pub3-BIB0005|cit5","first-page":"60","article-title":"Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy","volume":"23","author":"Baldi","year":"1991","journal-title":"Ital J Gastroenterol"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2036.1998.00397.x","article-title":"Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study","volume":"12","author":"Battaglia","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"10.1002\/14651858.CD003460.pub3-BIB0007|cit7","first-page":"1621","article-title":"Therapy of irritable colon with trimipramine (Herphonal) - A controlled clinical study","volume":"46","author":"Bergmann","year":"1991","journal-title":"Z Klin Med"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0008|cit8","first-page":"201","article-title":"Wirksamkeit ind vertraeglichkeit eines antidepressivums beim colon irritablie","volume":"38","author":"Boerner","year":"1988","journal-title":"Therapiewoche"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0009|cit9","first-page":"119","article-title":"Efficacy of peppermint oil in the treatment of irritable bowel syndrome: A randomized, controlled trial","volume":"164","author":"Capanni","year":"2005","journal-title":"Gazz Med Ital Arch Sci Med"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","article-title":"Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial","volume":"39","author":"Cappello","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0011|cit11","first-page":"1262","article-title":"Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome","volume":"83","author":"Centonze","year":"1988","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0012|cit12","first-page":"920","article-title":"SF-36 quality of life in effectiveness assessment for irritable bowel syndrome","volume":"12","author":"Chen","year":"2004","journal-title":"World Chin J Dig"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0013|cit13","first-page":"251","article-title":"Experiences with colpermintherapy (Tillots-England) at patients of irritable colon syndrome","volume":"34","author":"Czalbert","year":"1990","journal-title":"Gyogyszereszet"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0014|cit14","first-page":"649","article-title":"L'ottilonio bromuro nel trattamento della sindrome del colon irritabile","volume":"60","author":"d'Arienzo","year":"1980","journal-title":"Rass Int Clin Ter"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0015|cit15","first-page":"365","article-title":"The value of adding an antispasmodic musculotropic agent in the treatment of painful constipation in functional colopathies with bran. Double-blind study","volume":"10","author":"Delmont","year":"1981","journal-title":"Med Chir Dig"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/gut.31.3.355","article-title":"Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial","volume":"31","author":"Dobrilla","year":"1990","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1002\/14651858.CD003460.pub3-BIB0018|cit18","first-page":"1457","article-title":"Effet a court terme du bromure de pinaverium dans les oesophagites, gastro-duodenites et colopathies fonctionnelles","volume":"10","author":"Dubarry","year":"1977","journal-title":"Bordeaux Medical"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0019|cit19","first-page":"377","article-title":"Double blind trial of trimebutine in the irritable bowel syndrome","volume":"73","author":"Fielding","year":"1980","journal-title":"Ir Med J"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0022-3999(92)90026-X","article-title":"Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation","volume":"36","author":"Fowlie","year":"1992","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0021|cit21","first-page":"541","article-title":"Single drug treatment for irritable colon: Rociverine versus trimebutine maleate","volume":"39","author":"Ghidini","year":"1986","journal-title":"Curr Ther Res Clin Exp"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02943704","article-title":"The non-effect of pirenzepine in dietary resistant irritable bowel syndrome","volume":"158","author":"Gilvarry","year":"1989","journal-title":"Ir J Med Sci"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0033-3182(78)70930-8","article-title":"Irritable colon and depression","volume":"19","author":"Heefner","year":"1978","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1746.1990.tb01432.x","article-title":"Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction","volume":"5","author":"Jalihal","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000199329","article-title":"Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome","volume":"34","author":"Kruis","year":"1986","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","article-title":"The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study","volume":"1","author":"Kuiken","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"40","key":"10.1002\/14651858.CD003460.pub3-BIB0027|cit27","first-page":"2388","article-title":"Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo","volume":"150","author":"Lech","year":"1988","journal-title":"Ugeskr Laeger"},{"issue":"7-8","key":"10.1002\/14651858.CD003460.pub3-BIB0028|cit28","first-page":"372","article-title":"Pinaverium bromide and functional colonic disease (double-blind study)","volume":"53","author":"Levy","year":"1977","journal-title":"Sem Hop Ther"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF02936952","article-title":"Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial","volume":"32","author":"Liu","year":"1997","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-95-1-53","article-title":"Psyllium therapy in the irritable bowel syndrome. A double-blind trial","volume":"95","author":"Longstreth","year":"1981","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/gut.28.2.221","article-title":"Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study","volume":"28","author":"Lucey","year":"1987","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.psy.50.1.78","article-title":"A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome","volume":"50","author":"Masand","year":"2009","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1365-2036.2002.01277.x","article-title":"Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial","volume":"16","author":"Mitchell","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/030006057900700311","article-title":"A clinical trial of trimebutine (Mebutin) in spastic colon","volume":"7","author":"Moshal","year":"1979","journal-title":"J Int Med Res"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/00365528209181108","article-title":"The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study","volume":"17","author":"Myren","year":"1982","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0036|cit36","first-page":"1041","article-title":"Different therapeutic regimens in irritable bowel syndrome","volume":"32","author":"Nigam","year":"1984","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004836-198106000-00009","article-title":"Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride)","volume":"3","author":"Page","year":"1981","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2036.1989.tb00213.x","article-title":"Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome","volume":"3","author":"Passaretti","year":"1989","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0016-5085(79)90012-X","article-title":"Prifinium bromide in the treatment of the irritable colon syndrome","volume":"77","author":"Piai","year":"1979","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gut.28.11.1510","article-title":"Double blind study of ispaghula in irritable bowel syndrome","volume":"28","author":"Prior","year":"1987","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0041|cit41","first-page":"299","article-title":"Propinox in the treatment of irritable bowel syndrome","volume":"87","author":"Pulpeiro","year":"2000","journal-title":"Prensa Medica Argentina"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1440-1746.1998.tb00723.x","article-title":"Symptom relief with amitriptyline in the irritable bowel syndrome","volume":"13","author":"Rajagopalan","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/146642400512500112","article-title":"Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome","volume":"125","author":"Rees","year":"2005","journal-title":"J R Soc Health"},{"issue":"6160","key":"10.1002\/14651858.CD003460.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.1.6160.376","article-title":"Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk","volume":"1","author":"Ritchie","year":"1979","journal-title":"Br Med J"},{"issue":"25","key":"10.1002\/14651858.CD003460.pub3-BIB0045|cit45","first-page":"488","article-title":"The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon","volume":"108","author":"Schafer","year":"1990","journal-title":"Fortschr Med"},{"issue":"7954","key":"10.1002\/14651858.CD003460.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(76)91402-1","article-title":"A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome","volume":"1","author":"Soltoft","year":"1976","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2004.04127.x","article-title":"Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: A double-blind, placebo-controlled trial","volume":"99","author":"Tabas","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gut.2005.077503","article-title":"A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome","volume":"55","author":"Tack","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10620-007-9830-4","article-title":"Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial","volume":"53","author":"Talley","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","article-title":"The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study","volume":"22","author":"Vahedi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0052|cit52","first-page":"243","article-title":"Effect of antidepressant drug (doxepin) on irritable bowel syndrome patients","volume":"33","author":"Vij","year":"1991","journal-title":"Indian J Psychiatry"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0053|cit53","first-page":"32","article-title":"Colopathy pain and dicetel","volume":"43","author":"Virat","year":"1987","journal-title":"Prat Med"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0002-8223(21)05374-8","article-title":"Irritable bowel syndrome and dietary fiber","volume":"75","author":"Achord","year":"1979","journal-title":"J Am Diet Assoc"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/00002826-198912002-00009","article-title":"The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome","volume":"12 Suppl 2","author":"Alevizos","year":"1989","journal-title":"Clin Neuropharmacol"},{"issue":"19","key":"10.1002\/14651858.CD003460.pub3-BIB0056|cit56","first-page":"1673","article-title":"Basic treatment of spastic colon (multicenter trial with oxazepam plus scopolamine butyl nitrate)","volume":"8","author":"Andre","year":"1979","journal-title":"ARS MED INT TIJDSCHR PRAKT THER"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.1966.03100100103030","article-title":"Evaluation of an antispasmodic agent. Methixene hydrochloride (Trest)","volume":"195","author":"Anonymous","year":"1966","journal-title":"JAMA"},{"issue":"1298","key":"10.1002\/14651858.CD003460.pub3-BIB0058|cit58","first-page":"276","article-title":"Irritable colon syndrome treated with an antispasmodic drug","volume":"217","author":"Anonymous","year":"1976","journal-title":"Practitioner"},{"issue":"38","key":"10.1002\/14651858.CD003460.pub3-BIB0059|cit59","first-page":"1746","article-title":"Is pinaverium bromide suitable for treatment of spastic colon?","volume":"126","author":"Anonymous","year":"1982","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"24","key":"10.1002\/14651858.CD003460.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/dtb.24.24.93","article-title":"Some antispasmodic drugs for the irritable bowel syndrome","volume":"24","author":"Anonymous","year":"1986","journal-title":"Drug Ther Bull"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0061|cit61","first-page":"560, 562-4","article-title":"Effective and well-tolerated spasmolytic agent in the treatment of irritable colon syndrome","volume":"45","author":"Anonymous","year":"1995","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0062|cit62","first-page":"26","article-title":"Mebeverine suspension in childhood irritable bowel syndrome","volume":"12","author":"Anonymous","year":"1998","journal-title":"Arztliche Prax Padiatr"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0063|cit63","first-page":"755","article-title":"SSRIs to treat irritable bowel?","volume":"268","author":"Anonymous","year":"2002","journal-title":"Pharm J"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0064|cit64","first-page":"206","article-title":"Trimebutine: Another therapeutic choice for irritable bowel syndrome","volume":"7","author":"Anonymous","year":"2002","journal-title":"Chin J Gastroenterol"},{"issue":"50","key":"10.1002\/14651858.CD003460.pub3-BIB0065|cit65","first-page":"41","article-title":"Peppermint oil can relieve symptoms of irritable bowel syndrome","volume":"148","author":"Anonymous","year":"2008","journal-title":"Dtsch Apoth"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/00365528509091653","article-title":"The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study","volume":"20","author":"Arffmann","year":"1985","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0067|cit67","first-page":"247","article-title":"Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome","volume":"27","author":"Awad","year":"1997","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0068|cit68","first-page":"392","article-title":"Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study","volume":"39","author":"Baldi","year":"1992","journal-title":"Hepatogastroenterology"},{"issue":"21","key":"10.1002\/14651858.CD003460.pub3-BIB0069|cit69","first-page":"1879","article-title":"Double blind controlled trial of a new colonic antispasmodic agent, actylonium bromide","volume":"36","author":"Barbier","year":"1981","journal-title":"Ars Medici"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0070|cit70","first-page":"141","article-title":"Dietary fibers in gastroenterology","volume":"8","author":"Bassotti","year":"1988","journal-title":"MED RIV ENCICL MED ITAL"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1445-5994.1972.tb03904.x","article-title":"Mebeverine, an effective agent in the irritable colon syndrome","volume":"2","author":"Baume","year":"1972","journal-title":"Aust NZ J Med"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0011-393X(05)80445-X","article-title":"The effect of muscarinic blockade on anorectal function in patients with constipation-predominant irritable bowel syndrome","volume":"52","author":"Bazzocchi","year":"1992","journal-title":"Curr Ther Res Clin Exp"},{"issue":"16","key":"10.1002\/14651858.CD003460.pub3-BIB0073|cit73","first-page":"2341","article-title":"Etude controlee en double aveugle Duspatalin (Mebeverine) contre placebo, dans le traitement du colon irritable","volume":"88","author":"Berthelot","year":"1981","journal-title":"Gaz Med Fr"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0074|cit74","first-page":"277","article-title":"Treatment with antidepressants in biliary dyskinesia and irritable colon","volume":"41","author":"Birt","year":"1989","journal-title":"Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0075|cit75","first-page":"485","article-title":"Antidepressant therapy in functional gastrointestinal disorders","volume":"28","author":"Bixquert-Jimenez","year":"2005","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0076|cit76","first-page":"903","article-title":"Trimipramin (Surmontil) and placebo in irritable colon syndrome. A double-blind study","volume":"103","author":"Block","year":"1983","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clnu.2004.09.006","article-title":"Fiber effects on intestinal functions (diarrhoea, constipation and irritable bowel syndrome)","volume":"1","author":"Bosaeus","year":"2004","journal-title":"Clin Nutr Suppl"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0753-3322(01)80005-6","article-title":"Effects of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients","volume":"54","author":"Bouchoucha","year":"2000","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0079|cit79","first-page":"13","article-title":"The use of antidepressants in irritable bowel syndrome","volume":"26","author":"Budavari","year":"2002","journal-title":"Pract Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-277X.2001.00284.x","article-title":"Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice","volume":"14","author":"Burden","year":"2001","journal-title":"J Hum Nutr Diet"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0081|cit81","first-page":"174","article-title":"La terapia del colon irritabile. Risultati del trattamento con un nuovo antispastico: l'ottilonio bromuro","volume":"88","author":"Camarri","year":"1981","journal-title":"Policlinico [Prat]"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1185\/03007998609111090","article-title":"Fenoverine: Smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation","volume":"10","author":"Camarri","year":"1986","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0083|cit83","first-page":"509","article-title":"Functional colonic diseases and Mebeverine","volume":"42","author":"Camatte","year":"1966","journal-title":"Sem Ther"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gut.25.2.168","article-title":"What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?","volume":"25","author":"Cann","year":"1984","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0085|cit85","first-page":"67","article-title":"A multicenter controlled trial of a combination of kaolin, sterculia gum, meprobamate, and magnesium salts, in the irritable bowel syndrome (author's transl)","volume":"5","author":"Capron","year":"1981","journal-title":"Gastroenterol Clin Biol"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0086|cit86","first-page":"285","article-title":"The irritable bowel syndrome. A cross-over study of octilonium bromide, mebeverine and placebo","volume":"21","author":"Capurso","year":"1984","journal-title":"Clin Trials J"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0087|cit87","first-page":"121","article-title":"The octylonium bromide-benzodiazepine combination for management of the irritable bowel syndrome","volume":"141","author":"Capurso","year":"1992","journal-title":"Clin Ter"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0088|cit88","first-page":"55","article-title":"Short term treatment of the irritable bowel syndrome: A placebo-controlled trial of peppermint oil against hyoscyamine","volume":"34","author":"Carling","year":"1989","journal-title":"Opuscula Medica"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0089|cit89","first-page":"128","article-title":"Altmed watch. Peppermint oil holds its own as a treatment for IBS","volume":"46","author":"Cerrato","year":"2001","journal-title":"Contemp Ob Gyn"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1742-1241.1990.tb10058.x","article-title":"A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study","volume":"44","author":"Chapman","year":"1990","journal-title":"Br J Clin Pract"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2036.2007.03296.x","article-title":"Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol\/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study","volume":"25","author":"Chassany","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0092|cit92","first-page":"94","article-title":"Alverine\/dimeticone versus nifedipine in treating irritable bowel syndrome","volume":"18","author":"Chen","year":"1999","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0093|cit93","first-page":"806","article-title":"Paroxetine and Polyethylene Glycol (PEG) 4000 Therapy in Irritable Bowel Syndrome","volume":"18","author":"Chen","year":"2004","journal-title":"Chinese Mental Health Journal"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0094|cit94","first-page":"443","article-title":"Treatment of functional intestinal disorders with carbomucil","volume":"7","author":"Chevrel","year":"1978","journal-title":"Med Chir Dig"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0095|cit95","first-page":"7","article-title":"Fiber in the treatment of intestinal diseases","volume":"187","author":"Chicharro Serrano","year":"2007","journal-title":"Farm Hosp"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0306-3623(90)90439-S","article-title":"Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders","volume":"21","author":"Christen","year":"1990","journal-title":"Gen Pharmacol"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.1994.tb00308.x","article-title":"Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience","volume":"8","author":"Clouse","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/gut.52.4.598","article-title":"Antidepressants for irritable bowel syndrome","volume":"52","author":"Clouse","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0016-5085(90)91292-E","article-title":"Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study","volume":"98","author":"Cook","year":"1990","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0100|cit100","first-page":"713","article-title":"Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies","volume":"10","author":"Cop\u00e9","year":"1981","journal-title":"Med Chir Dig"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0101|cit101","first-page":"383","article-title":"Controlled clinical evaluation of pinaverium bromide and trimebutine in functional disorders of the colon","volume":"9","author":"Corazza","year":"1983","journal-title":"Acta Ther"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0102|cit102","first-page":"71A","article-title":"Role of opioid ligands in the irritable bowel syndrome","volume":"13 Suppl A","author":"Corazziari","year":"1999","journal-title":"Can J Gastroenterol"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","article-title":"The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome","volume":"124","author":"Creed","year":"2003","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/gut.2005.086348","article-title":"How do SSRIs help patients with irritable bowel syndrome?","volume":"55","author":"Creed","year":"2006","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0105|cit105","first-page":"736","article-title":"Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes","volume":"5","author":"Crowell","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0106|cit106","first-page":"882","article-title":"Irritable bowel syndrome and antidepressants","volume":"14","author":"Curtiss","year":"2008","journal-title":"J Manag Care Pharm"},{"issue":"1-6","key":"10.1002\/14651858.CD003460.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-4257(01)00020-1","article-title":"Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome","volume":"95","author":"Czimmer","year":"2001","journal-title":"J Physiol Paris"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0108|cit108","first-page":"461","article-title":"Clinical study of a new medication in the treatment of functional colopathies","volume":"10","author":"Darnis","year":"1981","journal-title":"Med Chir Dig"},{"issue":"8 Suppl 1","key":"10.1002\/14651858.CD003460.pub3-BIB0109|cit109","first-page":"64","article-title":"A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control","volume":"23","author":"Defrance","year":"1991","journal-title":"Ital J Gastroenterol"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0110|cit110","first-page":"524","article-title":"The effect of a new musculotropic subtance 9 (Mebeverine) on irritable colon","volume":"11","author":"Groote","year":"1968","journal-title":"Tijdschr Gastroenterol"},{"issue":"93","key":"10.1002\/14651858.CD003460.pub3-BIB0111|cit111","first-page":"3","article-title":"The combination fenoverine\/PVPP + karaya gum in the treatment of irritable bowel","volume":"9","author":"Garoullaye","year":"1991","journal-title":"Comptes Rendus de Therapeutique et de Pharmacologie Clinique"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/030006059702500501","article-title":"Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results","volume":"25","author":"Delvaux","year":"1997","journal-title":"J Int Med Res"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0113|cit113","first-page":"453","article-title":"A comparison between a fixed combination of ispaghula husk and mebeverine hydrochloride or mebeverine hydrochloride plus high-fibre dietary advice in the treatment of irritable bowel syndrome","volume":"1","author":"Dettmar","year":"1998","journal-title":"J Clin Res"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0114|cit114","first-page":"429","article-title":"A multicentre, general practice study of the effectiveness and acceptability of an ispaghula husk-mebeverine hydrochloride combination product in irritable bowel syndrome","volume":"1","author":"Dettmar","year":"1998","journal-title":"J Clin Res"},{"issue":"11-12","key":"10.1002\/14651858.CD003460.pub3-BIB0115|cit115","first-page":"394, 398","article-title":"Peppermint oil for the irritable bowel syndrome: a multicentre trial","volume":"38","author":"Dew","year":"1984","journal-title":"Br J Clin Pract"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0116|cit116","first-page":"420","article-title":"Effects of wheat bran in the irritable bowel syndrome","volume":"2","author":"Diaz-Rubio","year":"1985","journal-title":"Ann Med Interna"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0117|cit117","first-page":"97","article-title":"Octilonium bromide-diazepam versus propantheline bromide-bromazepam in the treatment of irritable bowel-syndrome: A multicenter, randomized, controlled, double-blind trial","volume":"5","author":"Dioguardi","year":"1991","journal-title":"Ter Mod"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0118|cit118","first-page":"13","article-title":"Bran in the treatment of irritable bowel syndrome","volume":"1","author":"Dubinin","year":"1987","journal-title":"Vopr Pitan"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2125.1985.tb02647.x","article-title":"The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome","volume":"19","author":"Ehsanullah","year":"1985","journal-title":"Br J Clin Pharmacol"},{"issue":"41","key":"10.1002\/14651858.CD003460.pub3-BIB0120|cit120","first-page":"2064","article-title":"The irritable colon syndrome. New therapeutic possibilities in the treatment of a frequent syndrome","volume":"96","author":"Eisenburg","year":"1978","journal-title":"Fortschr Med"},{"issue":"28","key":"10.1002\/14651858.CD003460.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/1381612043382972","article-title":"Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome","volume":"10","author":"Evangelista","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1532-5415.1998.tb01018.x","article-title":"Relation of colonic transit to functional bowel disease in older people: a population-based study","volume":"46","author":"Evans","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0123|cit123","first-page":"320","article-title":"Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome","volume":"8","author":"Ferrari","year":"1986","journal-title":"Clin Ther"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0124|cit124","first-page":"243","article-title":"Dietary fibre and the irritable bowel syndrome","volume":"33","author":"Fielding","year":"1979","journal-title":"J Hum Nutr"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02939822","article-title":"Different dietary fibre formulations and the irritable bowel syndrome","volume":"153","author":"Fielding","year":"1984","journal-title":"Ir J Med Sci"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1472-8206.1988.tb00617.x","article-title":"Inhibition of the colonic motor response to eating by pinaverium bromide in irritable bowel syndrome patients","volume":"2","author":"Fioramonti","year":"1988","journal-title":"Fundam Clin Pharmacol"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0127|cit127","first-page":"963","article-title":"The irritable bowel syndrome: the possible link between dietary fiber deficiency and disturbed intestinal motility","volume":"83","author":"Floch","year":"1988","journal-title":"Am J Gastroenterol"},{"issue":"8914","key":"10.1002\/14651858.CD003460.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(94)91055-3","article-title":"Bran and irritable bowel syndrome: time for reappraisal","volume":"344","author":"Francis","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00609689","article-title":"Effect of trimebutine on colonic myoelectrical activity in IBS patients","volume":"28","author":"Frexinos","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0130|cit130","first-page":"349","article-title":"Contribution to the treatment of colonic diseases. (Apropos of the uses of a new synthetic spasmolytic drug, mebeverine hydrochloride)","volume":"8","author":"Fritz","year":"1967","journal-title":"Rev Corps Sante.Armees Terre Mer Air"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0131|cit131","first-page":"496","article-title":"Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octilonium bromide in irritable colon: II. Multiple dose oral administration","volume":"4","author":"Galeone","year":"1986","journal-title":"Pharmatherapeutica"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0132|cit132","first-page":"613","article-title":"Pinaverium bromide versus otilonium bromide in patients with irritable bowel syndrome","volume":"39","author":"Galeone","year":"1986","journal-title":"Curr Ther Res Clin Exp"},{"issue":"33","key":"10.1002\/14651858.CD003460.pub3-BIB0133|cit133","first-page":"1610","article-title":"Investigation of the effect of a new spasmolytic preparation (Spasmeks) on spastic colon","volume":"133","author":"Geismar","year":"1971","journal-title":"Ugeskr Laeger"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0134|cit134","first-page":"1331","article-title":"The treatment of the irritable colon syndrome by a musculotropic antispasmodic: Duspatalin","volume":"84","author":"Geoffroy","year":"1977","journal-title":"Gaz Med Fr"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0135|cit135","first-page":"21","article-title":"Partially hyrdrolyzed guar gum: A fiber as coadiuvant in irritable bowel syndrome","volume":"152","author":"Giaccari","year":"2001","journal-title":"Clinica Terapeutica"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nut.2005.10.003","article-title":"Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome","volume":"22","author":"Giannini","year":"2006","journal-title":"Nutrition"},{"issue":"6165","key":"10.1002\/14651858.CD003460.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.1.6165.752-b","article-title":"Oral hyoscine butylbromide for irritable bowel syndrome?","volume":"1","author":"Gibbons","year":"1979","journal-title":"Br Med J"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1742-1241.2000.tb10900.x","article-title":"Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome","volume":"54","author":"Gilbody","year":"2000","journal-title":"Int J Clin Pract"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00042737-200212000-00008","article-title":"Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome","volume":"14","author":"Glende","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"37","key":"10.1002\/14651858.CD003460.pub3-BIB0140|cit140","first-page":"6411","article-title":"Value of high fiber diet in treatment of diverticulosis, constipation and irritable colon","volume":"27","author":"Gnauck","year":"1977","journal-title":"Therapiewoche"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0141|cit141","first-page":"353","article-title":"Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study)","volume":"30","author":"Golechha","year":"1982","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1994.tb00273.x","article-title":"Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome","volume":"8","author":"Gorard","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02063948","article-title":"Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome","volume":"40","author":"Gorard","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-95-5-660_1","article-title":"Psyllium and the irritable bowel syndrome","volume":"95","author":"Greenbaum","year":"1981","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0145|cit145","first-page":"622","article-title":"Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy","volume":"20","author":"Greenbaum","year":"1984","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01297051","article-title":"Effects of desipramine on irritable bowel syndrome compared with atropine and placebo","volume":"32","author":"Greenbaum","year":"1987","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.phymed.2004.10.005","article-title":"Peppermint oil in irritable bowel syndrome","volume":"12","author":"Grigoleit","year":"2005","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0148|cit148","first-page":"679","article-title":"Treatment of chronic colonic diseases with a new topical digestive agent, mucilage (karaya gum) combined with polyvinylpolypyrrolidone (P.V.P.P.)","volume":"8","author":"Guerre","year":"1979","journal-title":"Med Chir Dig"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1572-0241.2005.30375.x","article-title":"Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage","volume":"100","author":"Halpert","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2710.2008.00975.x","article-title":"Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release","volume":"34","author":"Han","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1572-0241.2002.05985.x","article-title":"Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms","volume":"97","author":"Hebden","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"6165","key":"10.1002\/14651858.CD003460.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.1.6165.752","article-title":"Oral hyoscine butylbromide for irritable bowel syndrome?","volume":"1","author":"Herxheimer","year":"1979","journal-title":"Br Med J"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0153|cit153","first-page":"645","article-title":"Effect of psyllium seeds compared to wheat bran on stool frequency and complaints in patients with irritable bowel syndrome and constipation","volume":"89","author":"Hotz","year":"1994","journal-title":"Medizinische Klinik"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.1997.00189.x","article-title":"Zamifenacin (UK-76, 654) a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome","volume":"11","author":"Houghton","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF03258483","article-title":"Clinical efficacy, safety and tolerance of mebeverine slow release (200 mg) vs mebeverine tablets in patients with irritable bowel syndrome","volume":"8","author":"Inauen","year":"1994","journal-title":"Drug Invest"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1254\/fpj.119.185","article-title":"Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)","volume":"119","author":"Iwanaga","year":"2002","journal-title":"Nippon Yakurigaku Zasshi"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0157|cit157","first-page":"163","article-title":"Peppermint oil for irritable bowel syndrome: Remedy or herbal folklore","volume":"1","author":"Jackson II","year":"1998","journal-title":"Integr Med"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0158|cit158","first-page":"5","article-title":"Phloroglucinol in irritable bowel syndrome","volume":"56","author":"Jafri","year":"2006","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0159|cit159","first-page":"369","article-title":"Role of pinaverium bromide in south Indian patients with irritable bowel syndrome","volume":"46","author":"Jayanthi","year":"1998","journal-title":"J Assoc Physicians India"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0160|cit160","first-page":"2275","article-title":"Evaluating the clinical effect and quality of life in the elderly with functional bowel disorder after treatment with pinaverium bromide","volume":"11","author":"Ji","year":"2007","journal-title":"J Clin Rehab Tissue Eng Res"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0161|cit161","first-page":"90","article-title":"Emotional disorders and treatment in patients with refractory irritable bowel syndrome","volume":"9","author":"Jing","year":"2004","journal-title":"Chin J Gastroenterol"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0162|cit162","first-page":"85","article-title":"Multicenter phase III clinical trial of otilonium bromide in irritable bowel syndrome","volume":"21","author":"Kaushik","year":"2002","journal-title":"Indian Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1176\/appi.ajp.157.9.1523-a","article-title":"Paroxetine and irritable bowel syndrome","volume":"157","author":"Kirsch","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1572-0241.1998.02304.x","article-title":"Peppermint oil and irritable bowel syndrome","volume":"93","author":"Koch","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0165|cit165","first-page":"209","article-title":"Dietary fiber and gastrointestinal disease","volume":"177","author":"Koruda","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0166|cit166","first-page":"193","article-title":"Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome","volume":"49","author":"Kountouras","year":"2002","journal-title":"Hepato-Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gut.28.2.150","article-title":"Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight","volume":"28","author":"Kumar","year":"1987","journal-title":"Gut"},{"issue":"20","key":"10.1002\/14651858.CD003460.pub3-BIB0168|cit168","first-page":"625","article-title":"Comparative studies of the effectiveness of brief psychotherapy, acupuncture and papaverin therapy in patients with irritable bowel syndrome","volume":"45","author":"Kunze","year":"1990","journal-title":"Z Gesamte Inn Med"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0169|cit169","first-page":"67","article-title":"Is the combination of kaolin, sterculia gum and magnesium superior to sound in the treatment of irritable colon? Controlled clinical trial","volume":"1","author":"Lafon","year":"1982","journal-title":"Rev Proct"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-277X.1989.tb00048.x","article-title":"A survey of high-fibre diet-sheets used in the treatment of irritable bowel syndrome in Great Britain","volume":"2","author":"Lambert","year":"1989","journal-title":"J Hum Nutr Diet"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0171|cit171","first-page":"601","article-title":"The value of prescribed 'high-fibre' diets for the treatment of the irritable bowel syndrome","volume":"45","author":"Lambert","year":"1991","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-277X.1991.tb00093.x","article-title":"Dietary fibre intake of irritable bowel patients prescribed a high fibre diet","volume":"4","author":"Lambert","year":"1991","journal-title":"J Hum Nutr Diet"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1440-1746.1988.tb00244.x","article-title":"Failure of enteric-coated peppermint oil in the irritable bowel syndrome: A randomized, double-blind crossover study","volume":"3","author":"Lawson","year":"1988","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0174|cit174","first-page":"109","article-title":"Treatment of colonic diverticulosis and irritable colon with wheat bran","volume":"8","author":"Levitan","year":"1981","journal-title":"Sov Med"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0175|cit175","first-page":"1926","article-title":"Effects of otilonium bromide on anorectal visceral sensorimotor functions of patients with diarrhea-predominant irritable bowel syndrome","volume":"11","author":"Lin","year":"2003","journal-title":"World Chin J Dig"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0176|cit176","first-page":"424","article-title":"Effect of subclincal dosage of antidepressants on refractory irritable bowel syndrome","volume":"14","author":"Liu","year":"2006","journal-title":"Chinese Journal of Clinical Psychology"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ebm.9.6.172","article-title":"Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome","volume":"9","author":"Locke","year":"2004","journal-title":"Evid Based Med"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1440-1746.2000.02230.x","article-title":"Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome","volume":"15","author":"Lu","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/030006057800600202","article-title":"A trial of trimebutine in spastic colon","volume":"6","author":"Luttecke","year":"1978","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1185\/03007998009109464","article-title":"A three-part controlled study of trimebutine in the treatment of irritable colon syndrome","volume":"6","author":"Luttecke","year":"1980","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0181|cit181","first-page":"40","article-title":"Psychopharmacology in the treatment of irritable bowel syndrome","volume":"14","author":"Lydiard","year":"2007","journal-title":"Prim Psychiatry"},{"issue":"6165","key":"10.1002\/14651858.CD003460.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.1.6165.752-a","article-title":"Oral hyoscine butylbromide for irritable bowel syndrome?","volume":"1","author":"MacRae","year":"1979","journal-title":"Br Med J"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0183|cit183","first-page":"822","article-title":"Cereal fibre and the irritable bowel: a controlled trial","volume":"17","author":"Manning","year":"1976","journal-title":"Gut"},{"issue":"8035","key":"10.1002\/14651858.CD003460.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(77)90605-5","article-title":"Wheat fibre and irritable bowel syndrome. A controlled trial","volume":"2","author":"Manning","year":"1977","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4088\/PCC.v10n0504","article-title":"History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study","volume":"10","author":"Marks","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0186|cit186","first-page":"63","article-title":"Clinical phase III comparative study of calcium polycarbophil tablet on irritable bowel syndrome - A double-blind study in comparison with torimebutine maleate","volume":"26","author":"Masamune","year":"1998","journal-title":"Jpn Pharmacol Ther"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0187|cit187","first-page":"12","article-title":"Paroxetine in patients with irritable bowel syndrome: A pilot open-label study","volume":"4","author":"Masand","year":"2002","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0188|cit188","first-page":"162","article-title":"Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study","volume":"7","author":"Masand","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1742-1241.1967.tb07119.x","article-title":"An assessment of dicyclomine hydrochloride ('Merbentyl') in the irritable colon syndrome","volume":"21","author":"Matts","year":"1967","journal-title":"Br J Clin Pract"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0190|cit190","first-page":"A33","article-title":"Symptoms and colonic transit time in the irritable bowel syndrome treated with psyllium and cisapride or placebo (abstract)","volume":"39 Suppl 3","author":"Meier","year":"1996","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.dld.2006.06.015","article-title":"Bran and irritable bowel syndrome: the primary-care perspective","volume":"38","author":"Miller","year":"2006","journal-title":"Dig Liver Dis"},{"issue":"270","key":"10.1002\/14651858.CD003460.pub3-BIB0192|cit192","first-page":"931","article-title":"Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial","volume":"73","author":"Misra","year":"1989","journal-title":"Q J Med"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0193|cit193","first-page":"263","article-title":"Single drug treatment for irritable colon syndrome: Rociverine 20 mg t.i.d","volume":"84","author":"Modena","year":"1993","journal-title":"Minerva Med"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0194|cit194","first-page":"129","article-title":"Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide","volume":"141","author":"Mollica","year":"1992","journal-title":"Clin Ter"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.2004.047423","article-title":"Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome","volume":"54","author":"Morgan","year":"2005","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/003693308703200420","article-title":"High fibre diets and irritable bowel syndrome - The role of the dietitian","volume":"32","author":"Morrison","year":"1987","journal-title":"Scott Med J"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365528708991878","article-title":"Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran","volume":"22","author":"Mortensen","year":"1987","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1742-1241.1986.tb07981.x","article-title":"Peppermint oil does not relieve the pain of irritable bowel syndrome","volume":"40","author":"Nash","year":"1986","journal-title":"Br J Clin Pract"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0199|cit199","first-page":"42","article-title":"Treatment of irritable bowel syndrome with dicetelium and spasmomen","volume":"78","author":"Nedogoda","year":"2000","journal-title":"Klin Med"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0200|cit200","first-page":"190","article-title":"A multicentric study of pinaverium bromide on irritable bowel syndrome, performed in Mexico","volume":"15","author":"Noel","year":"1989","journal-title":"Investigacion Medica Internacional"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S1092852900019866","article-title":"The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs","volume":"10","author":"Olden","year":"2005","journal-title":"CNS Spectr"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0202|cit202","first-page":"S74","article-title":"Double-blind parallel study of clebopride and hyoscine N-butylbromide in patients with irritable colon syndrome","volume":"31","author":"Pardell","year":"1982","journal-title":"Curr Ther Res Clin Exp"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1023\/A:1016419906546","article-title":"High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG)","volume":"47","author":"Parisi","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10620-005-2713-7","article-title":"Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial","volume":"50","author":"Parisi","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"19-20","key":"10.1002\/14651858.CD003460.pub3-BIB0205|cit205","first-page":"923","article-title":"Effect of tiropramide hydrochloride on the intestinal transit time in patients with irritable bowel syndrome","volume":"76","author":"Passaretti","year":"1985","journal-title":"Minerva Med"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0206|cit206","first-page":"47","article-title":"Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome","volume":"27","author":"Passaretti","year":"1989","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0207|cit207","first-page":"396","article-title":"How effective are antidepressant medications in the treatment of irritable bowel syndrome and nonulcer dyspepsia?","volume":"49","author":"Pearson","year":"2000","journal-title":"J Fam Pract"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0208|cit208","first-page":"83","article-title":"Glucomannan in treatment of irritable colon. Results of a controlled clinical trial","volume":"3","author":"Piai","year":"1987","journal-title":"Quaderni di Medicina e Chirurgia"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0209|cit209","first-page":"967","article-title":"Long-term treatment of irritable bowel syndrome with cimetropium bromide, a new antimuscarinic compound","volume":"41","author":"Piai","year":"1987","journal-title":"Curr Ther Res Clin Exp"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1572-0241.1998.00343.x","article-title":"Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis","volume":"93","author":"Pittler","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0211|cit211","first-page":"4","article-title":"Management of irritable bowel syndrome","volume":"40","author":"Prior","year":"1986","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003460.pub3-BIB0212|cit212","first-page":"A625","article-title":"A double blind study of ispaghula in irritable bowel syndrome (abstract)","volume":"27","author":"Prior","year":"1986","journal-title":"Gut"},{"issue":"1384","key":"10.1002\/14651858.CD003460.pub3-BIB0213|cit213","first-page":"1607","article-title":"The treatment of irritable bowel syndrome. Two doses of mebeverine compared","volume":"227","author":"Prout","year":"1983","journal-title":"Practitioner"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0214|cit214","first-page":"79","article-title":"Treatment of irritable bowel syndrome with pinaverium bromide","volume":"17","author":"Quilici","year":"1998","journal-title":"GED Gastrentologia Endosc Dig"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0215|cit215","first-page":"219","article-title":"Treatment of irritable bowel syndrome: Single drug therapy with mebeverine","volume":"22","author":"Quilici","year":"2003","journal-title":"GED Gastrentologia Endosc Dig"},{"issue":"33","key":"10.1002\/14651858.CD003460.pub3-BIB0216|cit216","first-page":"2415","article-title":"Treatment of irritable bowel with dietary fiber. A controlled clinical study","volume":"144","author":"Rasmussen","year":"1982","journal-title":"Ugeskr Laeger"},{"issue":"6194","key":"10.1002\/14651858.CD003460.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/bmj.2.6194.835","article-title":"Treating irritable bowel syndrome with peppermint oil","volume":"2","author":"Rees","year":"1979","journal-title":"Br Med J"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1552-4604.1978.tb01603.x","article-title":"Controlled clinical trial of sedative-anticholinergic drugs in patients with the irritable bowel syndrome","volume":"18","author":"Rhodes","year":"1978","journal-title":"J Clin Pharmacol"},{"issue":"Suppl","key":"10.1002\/14651858.CD003460.pub3-BIB0219|cit219","first-page":"E31","article-title":"Peppermint oil in enteric coated capsules for the treatment of irritable bowel syndrome: A double blind controlled trial","volume":"27","author":"Rhodes","year":"1980","journal-title":"Hepatogastroenterology"},{"issue":"6251","key":"10.1002\/14651858.CD003460.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.281.6251.1317","article-title":"Comparison of various treatments for irritable bowel syndrome","volume":"281","author":"Ritchie","year":"1980","journal-title":"Br Med J"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1176\/appi.psy.43.6.508","article-title":"Peppermint oil for irritable bowel syndrome","volume":"43","author":"Sagduyu","year":"2002","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1002\/14651858.CD003460.pub3-BIB0222|cit222","first-page":"1495","article-title":"Treatment for irritable bowel syndrome--psychotropic drugs, antidepressants and so on","volume":"64","author":"Sato","year":"2006","journal-title":"Nippon Rinsho"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0223|cit223","first-page":"136","article-title":"Comparative safety and efficacy of trimebutine versus mebeverine in the treatment of irritable bowel syndrome. A multicenter double-blind study","volume":"47","author":"Schaffstein","year":"1990","journal-title":"Curr Ther Res Clin Exp"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0224|cit224","first-page":"759-760, 762","article-title":"The treatment of irritable colon with mebeverine. Pain relief most important","volume":"8","author":"Schutz","year":"1992","journal-title":"Therapiewoche Schweiz"},{"issue":"13","key":"10.1002\/14651858.CD003460.pub3-BIB0225|cit225","first-page":"699","article-title":"Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon","volume":"74","author":"Secco","year":"1983","journal-title":"Minerva Med."},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0226|cit226","first-page":"29","article-title":"Role of dietary fibre in irritable bowel syndrome: a clinical study","volume":"41","author":"Sharma","year":"1987","journal-title":"Indian J Med Sci"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0227|cit227","first-page":"4, insert 2p","article-title":"Are antidepressants effective in the treatment of the functional gastrointestinal (GI) disorders of irritable bowel syndrome and nonulcer dyspepsia?","volume":"3","author":"Shaughnessy","year":"2000","journal-title":"Evid Based Pract"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0228|cit228","first-page":"616","article-title":"The role of tricyclics and benzodiazepine compounds in the treatment of irritable gut syndrome and peptic ulcer disease","volume":"20","author":"Shrivastava","year":"1984","journal-title":"Psychopharmacol Bull"},{"issue":"1-2","key":"10.1002\/14651858.CD003460.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.01.028","article-title":"Psyllium as therapeutic and drug delivery agent","volume":"334","author":"Singh","year":"2007","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1002\/14651858.CD003460.pub3-BIB0230|cit230","first-page":"3","article-title":"How do high-fiber supplements compare with guar gum for irritable bowel syndrome?","volume":"5","author":"Slawson","year":"2002","journal-title":"Evid Based Pract"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2036.1994.tb00323.x","article-title":"Bran supplementation in the treatment of irritable bowel syndrome","volume":"8","author":"Snook","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0232|cit232","first-page":"317","article-title":"Effects of medicinal fiber on colonic transit in patients with irritable colon syndrome","volume":"17","author":"Soifer","year":"1987","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0233|cit233","first-page":"37","article-title":"Manometric effects of pinaverium bromide in irritable bowel syndrome","volume":"22","author":"Soifer","year":"1992","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0234|cit234","first-page":"36","article-title":"Treatment of irritable bowel syndrome with a calcium antagonist (pinaverium bromide): experience with 40 cases","volume":"12","author":"Soriano","year":"1992","journal-title":"Rev Gastroenterol Peru"},{"issue":"47","key":"10.1002\/14651858.CD003460.pub3-BIB0235|cit235","first-page":"25","article-title":"Peppermint oil is helpful in irritable bowel syndrome","volume":"150","author":"Stiefelhagen","year":"2008","journal-title":"MMW-Fortschr Med"},{"issue":"22","key":"10.1002\/14651858.CD003460.pub3-BIB0236|cit236","first-page":"196","article-title":"Duodenogastric reflux in patients with irritable bowel syndrome treated with wheat bran","volume":"4","author":"Swiatczak","year":"1998","journal-title":"Pol Merkuriusz Lek"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1542-3565(03)70030-5","article-title":"SSRIs in IBS: sensing a dash of disappointment","volume":"1","author":"Talley","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1572-0241.2004.04128.x","article-title":"Antidepressants in IBS: are we deluding ourselves?","volume":"99","author":"Talley","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0239|cit239","first-page":"77","article-title":"Newer antidepressants in irritable bowel syndrome: What is the evidence?","volume":"4","author":"Talley","year":"2008","journal-title":"Arch Med Sci"},{"issue":"31","key":"10.1002\/14651858.CD003460.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.3748\/wjg.v13.i31.4161","article-title":"Fiber and colorectal diseases: Separating fact from fiction","volume":"13","author":"Tan","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","article-title":"A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin","volume":"31","author":"Tanum","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/003655200750022986","article-title":"Personality traits predict treatment outcome with an antidepressant in patients with functional gastrointestinal disorder","volume":"35","author":"Tanum","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0243|cit243","first-page":"119","article-title":"Efficacy of ground flaxseed on constipation in patients with irritable bowel syndrome","volume":"2","author":"Tarpila","year":"2002","journal-title":"Current Topics in Nutraceuticals Research"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0244|cit244","first-page":"525","article-title":"The irritable bowel syndrome: therapeutic effect of octilonium bromide alone and combined with a benzodiazepine. A double-blind study","volume":"109","author":"Tarquini","year":"1984","journal-title":"Clinica Terapeutica"},{"issue":"491","key":"10.1002\/14651858.CD003460.pub3-BIB0245|cit245","first-page":"232","article-title":"Mebeverine in patients with the irritable colon syndrome: double blind study","volume":"77","author":"Tasman-Jones","year":"1973","journal-title":"N Z Med J"},{"issue":"1-2","key":"10.1002\/14651858.CD003460.pub3-BIB0246|cit246","first-page":"23","article-title":"Controlled clinical trial of the effectiveness of tiropramide hydrochloride versus octylonium bromide in the treatment of irritable colon syndrome","volume":"75","author":"Tinozzi","year":"1984","journal-title":"Minerva Med"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0247|cit247","first-page":"17","article-title":"The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo","volume":"82","author":"Tomas-Ridocci","year":"1992","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0248|cit248","first-page":"261","article-title":"Single blind study of trimebutine and mebeverine in irritable colon and dyspepsia","volume":"7","author":"Toussaint","year":"1981","journal-title":"Acta Ther"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0249|cit249","first-page":"201","article-title":"Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double blind randomised study)","volume":"31","author":"Tripathi","year":"1983","journal-title":"J Assoc Physicians India"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0250|cit250","first-page":"307","article-title":"Clinical evaluation of TM 906 (trimebutine maleate) in the treatment of irritable bowel syndrome. Multi center double blind study in comparison with mepenzolate bromide","volume":"15","author":"Tsuneoka","year":"1987","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"7","key":"10.1002\/14651858.CD003460.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1742-1241.1986.tb07977.x","article-title":"A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome","volume":"40","author":"Tudor","year":"1986","journal-title":"Br J Clin Pract"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0252|cit252","first-page":"733; author rep","article-title":"The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome","volume":"56","author":"Kerkhoven","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2710.1995.tb00663.x","article-title":"A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome","volume":"20","author":"Outryve","year":"1995","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/0016-5085(90)91202-H","article-title":"Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome","volume":"99","author":"Steensel","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0255|cit255","first-page":"67","article-title":"Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome","volume":"8 Suppl 1","author":"Villagrasa","year":"1991","journal-title":"Ital J Gastroenterol"},{"issue":"12","key":"10.1002\/14651858.CD003460.pub3-BIB0256|cit256","first-page":"1652","article-title":"Fiber supplements for irritable bowel syndrome: do they really make a difference?","volume":"85","author":"Wald","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003460.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/00004836-200207001-00010","article-title":"Psychotropic agents in irritable bowel syndrome","volume":"35","author":"Wald","year":"2002","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0258|cit258","first-page":"74","article-title":"Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants","volume":"25","author":"Wang","year":"2003","journal-title":"Chung-Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao"},{"issue":"9","key":"10.1002\/14651858.CD003460.pub3-BIB0259|cit259","first-page":"469","article-title":"Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome","volume":"140","author":"Wittmann","year":"1999","journal-title":"Orv Hetil"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-277x.2000.00240.x","article-title":"Clinical audit of the effects of low-fibre diet on irritable bowel syndrome","volume":"13","author":"Woolner","year":"2000","journal-title":"J Hum Nutr Diet"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0261|cit261","first-page":"279","article-title":"Efficacy and safety of otilonium bromide for irritable bowel syndrome","volume":"8","author":"Yuan","year":"2003","journal-title":"Chin J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0262|cit262","first-page":"143","article-title":"Efficacy and safety use of trimebutine maleate in treatment of irritable bowel syndrome","volume":"10","author":"Yuan","year":"2005","journal-title":"Chin.J.Gastroenterol."},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0263|cit263","first-page":"328","article-title":"Effects of treatments with otilonium bromide, collodal bismuth tartrate and compound diphenoxylate in the irritable bowel syndrome: a double-blind random controlled study","volume":"18","author":"Zhang","year":"2002","journal-title":"The Chinese Journal of Clinical Pharmacology"},{"issue":"23","key":"10.1002\/14651858.CD003460.pub3-BIB0264|cit264","first-page":"3576","article-title":"Effect of paroxetine hydrochloride and pinaverium bromide therapy in patients with irritable bowel syndrome","volume":"6","author":"Zhou","year":"2002","journal-title":"Chin J Clin Rehab"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.mcg.0000196405.15110.bb","article-title":"The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations","volume":"40","author":"Zuckerman","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"29","key":"10.1002\/14651858.CD003460.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3748\/wjg.15.3636","article-title":"A randomized controlled trial of imipramine in patients with irritable bowel syndrome","volume":"15","author":"Abdul-Baki","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial","volume":"339","author":"Bijkerk","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-230X-10-136","article-title":"Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)","volume":"10","author":"Everitt","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0269|cit269","first-page":"17","article-title":"Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics)","volume":"18","author":"Khalif","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2009.09.008","article-title":"Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome","volume":"8","author":"Ladabaum","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10620-009-0854-9","article-title":"The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome","volume":"55","author":"Merat","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0272|cit272","first-page":"155","article-title":"Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial","volume":"14","author":"Pace","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpsychores.2010.01.003","article-title":"Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care","volume":"68","author":"Reme","year":"2010","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1002\/14651858.CD003460.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2009.06.060","article-title":"Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders","volume":"137","author":"Saps","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2009.04216.x","article-title":"Clinical trial: the efficacy of alverine citrate\/simeticone combination on abdominal pain\/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study","volume":"31","author":"Wittmann","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/gut.48.2.272","article-title":"Treatment of irritable bowel syndrome: A review of randomised controlled trials","volume":"48","author":"Akehurst","year":"2001","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0269-2813.2004.01862.x","article-title":"Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome","volume":"19","author":"Bijkerk","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003460.pub3-BIB0278|cit278","first-page":"S7","article-title":"Systematic review on the management of irritable bowel syndrome in North America","volume":"97","author":"Brandt","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"7792","key":"10.1002\/14651858.CD003460.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(72)92974-1","article-title":"Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease","volume":"2","author":"Burkitt","year":"1972","journal-title":"Lancet"},{"issue":"9 Pt 2","key":"10.1002\/14651858.CD003460.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00010","article-title":"Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome","volume":"134","author":"Creed","year":"2001","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ajg.2009.658","article-title":"Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome","volume":"105","author":"Ford","year":"2010","journal-title":"The American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2036.2004.02034.x","article-title":"Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population","volume":"20","author":"Hillila","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2005.11.058","article-title":"Design of treatment trials for functional gastrointestinal disorders","volume":"130","author":"Irvine","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"Am J Med"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","article-title":"Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials","volume":"133","author":"Jailwala","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD003460.pub3-BIB0290|cit290","first-page":"ii1","article-title":"British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome","volume":"47 Suppl 2","author":"Jones","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003460.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.46.1.7","article-title":"IBS: prime problem in primary care","volume":"46","author":"Jones","year":"2000","journal-title":"Gut"},{"issue":"11-12","key":"10.1002\/14651858.CD003460.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2036.2004.02267.x","article-title":"Meta-analysis: The treatment of irritable bowel syndrome","volume":"20","author":"Lesbros-Pantoflickova","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1572-0241.2003.07296.x","article-title":"Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective","volume":"98","author":"Longstreth","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"6138","key":"10.1002\/14651858.CD003460.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.2.6138.653","article-title":"Towards positive diagnosis of the irritable bowel","volume":"2","author":"Manning","year":"1978","journal-title":"Br Med J"},{"issue":"10","key":"10.1002\/14651858.CD003460.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1726-35; discus","DOI":"10.1016\/j.clinthera.2006.10.010","article-title":"Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study","volume":"28","author":"Pare","year":"2006","journal-title":"Clin Ther"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2036.1994.tb00322.x","article-title":"Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome","volume":"8","author":"Poynard","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1002\/14651858.CD003460.pub3-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","article-title":"Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome","volume":"15","author":"Poynard","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"10.1002\/14651858.CD003460.pub3-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3748\/wjg.15.1548","article-title":"Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis","volume":"15","author":"Rahimi","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1002\/14651858.CD003460.pub3-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpsychores.2008.02.021","article-title":"Somatic comorbidities of irritable bowel syndrome: a systematic analysis","volume":"64","author":"Riedl","year":"2008","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1002\/14651858.CD003460.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1572-0241.2006.00519.x","article-title":"Measuring successful treatment of irritable bowel syndrome: is \"satisfactory relief \" enough?","volume":"101","author":"Schoenfeld","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.2006.02938.x","article-title":"Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective","volume":"24","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1002\/14651858.CD003460.pub3-BIB0302|cit302","first-page":"72","article-title":"A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut?","volume":"6","author":"Talley","year":"2006","journal-title":"Rev Gastroenterol Disord"},{"issue":"18","key":"10.1002\/14651858.CD003460.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2165\/0003495-200868180-00007","article-title":"Antidepressants for the treatment of chronic pain","volume":"68","author":"Verdu","year":"2008","journal-title":"Drugs"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003460.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:15:12Z","timestamp":1725470112000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003460.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,10]]},"references-count":303,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003460.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,10]]}}}